Schizophrenia Clinical Trial
Official title:
Online Left-hemispheric Frontoparietal Theta In-phase tACS During Working Memory Training in Schizophrenia Patients: A Pilot Randomized Double-blind, Sham-controlled Study of the Effects on Negative Symptoms
In this randomized double-blind trial, we investigated whether externally induced left-hemispheric frontoparietal theta synchronization by multi-electrode online theta (6Hz) transcranial alternating current stimulation (tACS) would enhance the influence of a working memory training on negative symptoms of schizophrenia.
Negative symptoms have a negative impact on the prognosis of schizophrenia, but effective
treatment for this symptom dimension is still under investigation. Identifying a treatment
target that has a close link to negative symptoms or highly impacts negative symptoms may
help to develop an effective therapy to counteract negative symptoms of schizophrenia. Recent
theoretical and empirical work linking negative symptoms and cognitive impairment in
schizophrenia has identified a potential treatment target: cognitive deficits. Evidence has
indicated that cognitive remediation (CR) has a positive effect on improving negative
symptoms of schizophrenia, in particular behavioural negative symptoms.
Although it is still debated which active components of CR contribute to the improvements in
negative symptoms. The framework proposed by Gold and colleagues may be a candidate to
explain how CR improves negative symptoms (i.e., possible through improving working memory).
Anhedonia (i.e., the diminished ability to experience pleasure and reduced reactivity to
pleasurable stimuli) represents a challenging negative symptom in schizophrenia.The
impairment in hedonic processing has been associated with reduced motivation to engage in
potentially rewarding events. Working memory (WM) plays an important role in the formation,
maintenance, and retrieval of affective and value representations, all of which are essential
for anticipatory pleasure. Individuals represent events and forecast pleasure by using WM in
order to recruit motivational resources. It has been suggested that there is a hedonic
detector system within the WM model and that WM serves as a potential underlying cognitive
mechanism for anticipatory pleasure and goal-related behaviours. Problems in WM may reduce
the ability to retrieve and manipulate information to motivate and guide future behaviour,
thereby contributing to diminished motivation and the pleasure experience. It is known that
the recruitment of the prefrontal-striatal system (including dorsolateral prefrontal cortex,
cingulate cortex, insula, and ventral striatum) implicates in hedonic processing. It is also
known that the same brain regions can be viewed as core brain regions of the WM network
because they are activated during WM load. The overlap in activation of the
prefrontal-striatal system during hedonic processing and WM provides robust evidence
supporting the relationship between hedonic capacity and WM. Evidence indicated a correlation
between the activity in WM brain networks and the improvement in negative symptoms following
antipsychotic treatment, suggesting a mediating effect of WM on negative symptoms improvement
in the context of a pharmacological intervention. More recently, studies indicated that 20
sessions of WM training (dual n-back task training) showed neural transfer effect to enhance
hedonic processing in individuals with high social anhedonia and ameliorate hedonic
dysfunction in schizophrenia patients with prominent negative symptoms.
In addition to WM training, non-invasive brain stimulation (NIBS) is also a
non-pharmacological method to improve brain neural plasticity. For example, repetitive
transcranial magnetic stimulation (rTMS) can change the activity of cortical nerve
temporarily or continuously and enhance neural plasticity. However, the ability of rTMS alone
to improve cognitive function in schizophrenia is frequently limited to some extent,
necessitating a combination with WM training to boost cognitive functions.
Transcranial alternating current stimulation (tACS), a safe NIBS technique that applies
low-intensity alternating current, is also a potential therapeutic option in treating the
cognitive impairment in schizophrenia. The stimulation frequency of tACS is usually set to
coincide with the targeted brain endogenous rhythms. It would synchronize the neural
oscillations in the stimulated cortical regions to the applied stimulation frequency.
Different tACS current intensity (0.5 to 4 mA), stimulation frequency (0.1 to 80 Hz),
electrode montages, phase difference across the stimulation site, with/without DC offset, and
the states (e.g., at rest or concurrently under the tasks) during stimulation contribute to
its different effects. If both the target electrode and the reference electrode are in the
same phase of the cycle of the current at any given time, the phase difference will be 0
degree (i.e., in-phase). The phase difference will be 180 degrees (i.e., anti-phase) if the
electrodes are in the opposite phase. In-phase and anti-phase tACS over brain regions elicits
synchronization and desynchronization of neuronal activity across the brain regions,
respectively.
The state-dependent tACS effects indicate that the effects of tACS are enhanced when the
state of the targeted brain regions is active. Specifically, synchronization of
frontoparietal regions at theta frequencies dominates during an executive task. tACS at the
frequency close to the theta oscillation activated by an executive task would elicit more
resonance and may, in turn, help to enhance executive function. tACS applied when an
individual is concurrently engaged in a specific cognitive task is defined as online tACS. In
healthy subjects, online theta (6Hz) in-phase tACS facilitated frontoparietal phase coupling
(synchronization) resulting in improved WM performance, whereas online theta (6Hz) anti-phase
tACS disrupted theta phase-coupling (desynchonization) resulting in impaired WM performance.
The prolonged after-effects of tACS may be related to a phenomenon called
spike-timing-dependent plasticity (STDP), a process that modifies the connection strengths
based on the relative timing of the input and output spikes (or action potentials) of a
neuron. STDP means that synapse will be strengthened if input action potentials occur
immediately before the output action potentials, and synapse will be made weaker if an input
action potentials occur immediately after an output action potentials. The STDP process is
known to explain in part long-term depression (LTD) and long-term potentiation (LTP) of
nervous systems. To sum up, tACS at a frequency close to that of resonance frequency during
tACS may intensify the synapses across the stimulated regions through the mechanism of STDP.
Repetitive (multiple-session) tACS during specific time intervals may consolidate the
neuroplasticity effects, and may, in turn, elicit a long-lasting effect for further clinical
application in treating neuropsychiatric disorders. In schizophrenia patients, a few case
reports indicated 1-5 sessions of online theta in-phase tACS over left frontoparietal regions
improved the performance of WM and several other cognitive domains.
So far, there is no relevant research report exploring whether and how the joint intervention
(i.e., online theta (6Hz) in-phase tACS over the left frontoparietal regions plus WM
training) will have a combined effect on improving the performance of WM and other cognitive
domains in schizophrenic patients. Neither is any research investigating whether online theta
(6Hz) in-phase tACS over the left frontoparietal regions can potentiate the effects of WM
training on improving negative symptoms of schizophrenia. To sum up, we hypothesize that the
combination training mode of active online theta tACS plus WM training would have a greater
ability to reduce negative symptoms of schizophrenia compared to the training mode of sham
online theta tACS plus WM training. The study aims to test the efficacy of "active online
theta tACS plus WM" versus "sham online theta tACS plus WM training" in improving negative
symptoms, WM performance, and other cognitive domains performance of schizophrenia using a
double-blinded, randomized sham-controlled trial design. In order to evaluate the efficacy of
the interventions, we will use behavioral outcomes (e.g., negative symptoms assessment and
neurocognitive assessment) and neurophysiological outcomes (e.g., EEG and heart rate
variability).
Methods
Dual N back training
The study will use a dual n-back task for WM training. In this task, squares at 8 different
locations will show up sequentially (stimulus length, 500 ms; inter-stimulus interval, 2,500
ms) on a computer screen every 3 seconds. Simultaneously with the presentation of the
squares, one of eight consonants will show up sequentially through a speaker. Participants
will have to judge whether the location of a square and the consonant they heard matches the
one n-back before (the same n value for both visual and auditory targets). Each training
session has 20 blocks consisting of 20 + n trials and takes around 25 min. Each block
includes six auditory and six visual targets (four appearing in only one modality, and two
appearing in both modalities simultaneously) whose locations are random. Participants will
have to make responses manually by pressing the mouse left-click button for visual targets
and the right-click button for auditory targets. No responses were required for non-targets.
If a target is correctly detected, a green flash will be given, which constitutes a positive
feedback. If a target is falsely detected, a blue flash will be given, which constitutes a
negative feedback. The dual N back training is designed to continuously vary its difficulty
by modifying the WM load (i.e., the level of n) and thereby track the participants'
performance. Each training session begins at n = 1. Participants' performance will be
analyzed after each block and the level of n for the next block will be adapted according to
the following principle. The level of n increases by 1 in the next block if the mistakes per
modality made by the participant are<3. Conversely, n would decrease by 1 if the mistakes per
modality made by the participant are>5. In all other cases, the n is kept unchanged.
Participants will come to the laboratory and take part in the WM training sessions twice
daily for 5 weekdays (total 10 sessions), with each session lasting for approximately 25
minutes. The time interval between twice-daily sessions will be >3 hours.
Online left-hemispheric frontoparietal theta (6Hz) in-phase tACS
θ tACS will be administered during the dual n-back task, starting at the beginning of each
task and lasting for 20 min. In the active θ tACS condition, sinusoidal tACS will be
delivered by two battery-operated devices connected with two 4 × 1 wire adaptors (Equalizer
Box, NeuroConn, Ilmenau, Germany). The electrode montages used for θ tACS will be positioned
at left frontoparietal locations. The stimulation electrodes of the 1st stimulator will be
placed at the International 10-10 electrode position F1, F5, AF3, and FC3 (stimulation
electrodes) and CPz (return electrode) to cover the left frontal cortex. For the 2nd
stimulator, the stimulation electrodes will be placed at P1, P5, CP3, and PO3 (stimulation
electrodes) and FCz (return electrode) to cover the left parietal cortex. A NeuroConn digital
to analog converter (DAQ) will control the two stimulators and create an in-phase
(synchronous) setup (0° relative phase difference between the output signals of the two
tACS-stimulators).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |